Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer

R. T. Eagan, S. Frytak, W. C. Nichols, J. N. Ingle, E. T. Creagan, L. K. Kvols

Research output: Contribution to journalArticlepeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)517-519
Number of pages3
JournalCancer Treatment Reports
Issue number5-6
StatePublished - 1981

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this